Comprehensive Stock Comparison
Compare Solventum Corporation (SOLV) vs American Shared Hospital Services (AMS) Stock
Analyze side-by-side fundamentals, valuation, growth, and profitability to decide which stock is the better buy.
Selected Stocks
Add up to 10 tickers. Use presets or search to get started.
Quick Verdict
| Category | Winner | Why |
|---|---|---|
| Growth | AMS | 32.9% revenue growth vs SOLV's 0.9% |
| Value | AMS | Lower P/E (6.4x vs 11.5x) |
| Quality / Margins | SOLV | 18.7% net margin vs AMS's -7.6% |
| Stability / Safety | AMS | Lower D/E ratio (77.4% vs 99.7%) |
| Dividends | Tie | Neither pays a meaningful dividend |
| Momentum (1Y) | SOLV | -7.0% vs AMS's -28.0% |
| Efficiency (ROA) | SOLV | 10.9% ROA vs AMS's -3.8%, ROIC 16.9% vs -5.8% |
Who Each Stock Is For
Growth exposure
Long-term compounding (10Y)
Sleep-well-at-night portfolio
Defensive / Recession hedge
Business Model
What each company does and how it makes money
Solventum is a healthcare company that develops, manufactures, and commercializes medical solutions across four main segments. It generates revenue primarily from medical surgical supplies (~40% of sales), dental products (~25%), health information systems software (~20%), and purification/filtration technologies (~15%). The company benefits from its established brand recognition and comprehensive product portfolio—spanning from wound care to dental orthodontics—which creates switching costs for healthcare providers.
American Shared Hospital Services is a specialized medical equipment leasing company that provides Gamma Knife radiosurgery systems and proton beam radiation therapy equipment to healthcare providers. It generates revenue primarily through equipment leasing arrangements — typically taking a percentage of procedure fees — and also offers financing, installation, and support services. The company's moat lies in its specialized focus on high-cost, technologically advanced radiation therapy equipment that requires significant capital investment, creating barriers to entry for smaller competitors.
Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Financial Metrics Comparison
Side-by-side fundamentals across 2 stocks. BestLagging
Financial Scorecard
SOLV leads in 3 of 6 categories (Financial Metrics, Profitability & Efficiency). AMS leads in 1 (Valuation Metrics). 1 tied.
Financial Metrics (TTM)
SOLV is the larger business by revenue, generating $8.3B annually — 282.9x AMS's $29M. SOLV is the more profitable business, keeping 18.7% of every revenue dollar as net income compared to AMS's -7.6%. On growth, AMS holds the edge at +2.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | SOLVSolventum Corpora… | AMSAmerican Shared H… |
|---|---|---|
| RevenueTrailing 12 months | $8.3B | $29M |
| EBITDAEarnings before interest/tax | $2.9B | $2M |
| Net IncomeAfter-tax profit | $1.6B | -$2M |
| Free Cash FlowCash after capex | -$9M | -$10M |
| Gross MarginGross profit ÷ Revenue | +53.5% | +25.0% |
| Operating MarginEBIT ÷ Revenue | +26.2% | -12.3% |
| Net MarginNet income ÷ Revenue | +18.7% | -7.6% |
| FCF MarginFCF ÷ Revenue | -0.1% | -34.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | -3.7% | +2.5% |
| EPS Growth (YoY)Latest quarter vs prior year | +105.6% | -56.7% |
Valuation Metrics
At 6.4x trailing earnings, AMS trades at a 23% valuation discount to SOLV's 8.4x P/E. On an enterprise value basis, AMS's 7.7x EV/EBITDA is more attractive than SOLV's 7.8x.
| Metric | SOLVSolventum Corpora… | AMSAmerican Shared H… |
|---|---|---|
| Market CapShares × price | $12.9B | $14M |
| Enterprise ValueMkt cap + debt − cash | $17.0B | $26M |
| Trailing P/EPrice ÷ TTM EPS | 8.36x | 6.39x |
| Forward P/EPrice ÷ next-FY EPS est. | 11.54x | — |
| PEG RatioP/E ÷ EPS growth rate | — | 0.97x |
| EV / EBITDAEnterprise value multiple | 7.81x | 7.70x |
| Price / SalesMarket cap ÷ Revenue | 1.55x | 0.48x |
| Price / BookPrice ÷ Book value/share | 2.58x | 0.47x |
| Price / FCFMarket cap ÷ FCF | — | — |
Profitability & Efficiency
SOLV delivers a 30.8% return on equity — every $100 of shareholder capital generates $31 in annual profit, vs $-8 for AMS. AMS carries lower financial leverage with a 0.77x debt-to-equity ratio, signaling a more conservative balance sheet compared to SOLV's 1.00x. On the Piotroski fundamental quality scale (0–9), SOLV scores 6/9 vs AMS's 5/9, reflecting solid financial health.
| Metric | SOLVSolventum Corpora… | AMSAmerican Shared H… |
|---|---|---|
| ROE (TTM)Return on equity | +30.8% | -7.9% |
| ROA (TTM)Return on assets | +10.9% | -3.8% |
| ROICReturn on invested capital | +16.9% | -5.8% |
| ROCEReturn on capital employed | +19.0% | -6.4% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 |
| Debt / EquityFinancial leverage | 1.00x | 0.77x |
| Net DebtTotal debt minus cash | $4.2B | $12M |
| Cash & Equiv.Liquid assets | $878M | $11M |
| Total DebtShort + long-term debt | $5.0B | $23M |
| Interest CoverageEBIT ÷ Interest expense | 5.62x | -1.35x |
Total Returns (with DRIP)
A $10,000 investment in SOLV five years ago would be worth $9,275 today (with dividends reinvested), compared to $8,115 for AMS. Over the past 12 months, SOLV leads with a -7.0% total return vs AMS's -28.0%. The 3-year compound annual growth rate (CAGR) favors SOLV at -2.5% vs AMS's -16.9% — a key indicator of consistent wealth creation.
| Metric | SOLVSolventum Corpora… | AMSAmerican Shared H… |
|---|---|---|
| YTD ReturnYear-to-date | -6.1% | +0.5% |
| 1-Year ReturnPast 12 months | -7.0% | -28.0% |
| 3-Year ReturnCumulative with dividends | -7.2% | -42.7% |
| 5-Year ReturnCumulative with dividends | -7.3% | -18.8% |
| 10-Year ReturnCumulative with dividends | -7.2% | +15.3% |
| CAGR (3Y)Annualised 3-year return | -2.5% | -16.9% |
Risk & Volatility
AMS is the less volatile stock with a -0.01 beta — it tends to amplify market swings less than SOLV's 0.97 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SOLV currently trades 84.1% from its 52-week high vs AMS's 67.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | SOLVSolventum Corpora… | AMSAmerican Shared H… |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.97x | -0.01x |
| 52-Week HighHighest price in past year | $88.20 | $3.11 |
| 52-Week LowLowest price in past year | $60.70 | $2.01 |
| % of 52W HighCurrent price vs 52-week peak | +84.1% | +67.8% |
| RSI (14)Momentum oscillator 0–100 | 50.9 | 48.1 |
| Avg Volume (50D)Average daily shares traded | 788K | 7K |
Analyst Outlook
| Metric | SOLVSolventum Corpora… | AMSAmerican Shared H… |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | — |
| Price TargetConsensus 12-month target | $95.80 | — |
| # AnalystsCovering analysts | 11 | — |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | 0 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
Historical Charts
Charts are rendered on first load. Hover for details.
Chart 1Total Return — 5 Years (Rebased to 100)
| Stock | Mar 24 | Feb 26 | Change |
|---|---|---|---|
| Solventum Corporati… (SOLV) | 100 | 96.14 | -3.9% |
| American Shared Hos… (AMS) | 100 | 72.7 | -27.3% |
Solventum Corporati… (SOLV) returned -7% over 5 years vs American Shared Hos… (AMS)'s -19%.
Chart 2Revenue Growth — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Solventum Corporati… (SOLV) | $8.2B | $8.3B | +1.9% |
| American Shared Hos… (AMS) | $19M | $28M | +51.6% |
Chart 3Net Margin Trend — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Solventum Corporati… (SOLV) | 17.9% | 18.7% | +4.6% |
| American Shared Hos… (AMS) | 5.0% | 7.7% | +55.1% |
Chart 4P/E Ratio History — 7 Years
| Stock | 2017 | 2024 | Change |
|---|---|---|---|
| American Shared Hos… (AMS) | 7.9 | 9.7 | +22.8% |
American Shared Hospital Services has traded in a 8x–74x P/E range over 7 years; current trailing P/E is ~6x.
Chart 5EPS Growth — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Solventum Corporati… (SOLV) | 8.47 | 8.88 | +4.8% |
| American Shared Hos… (AMS) | 0.17 | 0.33 | +94.1% |
Chart 6Free Cash Flow — 5 Years
Solventum Corporation generated $-10M FCF in 2025 (-101% vs 2021). American Shared Hospital Services generated $-8M FCF in 2024 (-269% vs 2021).
SOLV vs AMS: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is SOLV or AMS a better buy right now?
American Shared Hospital Services (AMS) offers the better valuation at 6.4x trailing P/E, making it the more compelling value choice. Analysts rate Solventum Corporation (SOLV) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SOLV or AMS?
On trailing P/E, American Shared Hospital Services (AMS) is the cheapest at 6.4x versus Solventum Corporation at 8.4x.
03Which is the better long-term investment — SOLV or AMS?
Over the past 5 years, Solventum Corporation (SOLV) delivered a total return of -7.3%, compared to -18.8% for American Shared Hospital Services (AMS). A $10,000 investment in SOLV five years ago would be worth approximately $9K today (assuming dividends reinvested). Over 10 years, the gap is even starker: AMS returned +15.3% versus SOLV's -7.2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SOLV or AMS?
By beta (market sensitivity over 5 years), American Shared Hospital Services (AMS) is the lower-risk stock at -0.01β versus Solventum Corporation's 0.97β — meaning SOLV is approximately -8967% more volatile than AMS relative to the S&P 500. On balance sheet safety, American Shared Hospital Services (AMS) carries a lower debt/equity ratio of 77% versus 100% for Solventum Corporation — giving it more financial flexibility in a downturn.
05Which has better profit margins — SOLV or AMS?
Solventum Corporation (SOLV) is the more profitable company, earning 18.7% net margin versus 7.7% for American Shared Hospital Services — meaning it keeps 18.7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SOLV leads at 26.2% versus -9.9% for AMS. At the gross margin level — before operating expenses — SOLV leads at 53.5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — SOLV or AMS?
None of the stocks in this comparison currently pay a material dividend. All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is SOLV or AMS better for a retirement portfolio?
For long-horizon retirement investors, American Shared Hospital Services (AMS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.01)). Both have compounded well over 10 years (AMS: +15.3%, SOLV: -7.2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between SOLV and AMS?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that beat both.